Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carboplatin, Paclitaxel, and Temozolomide in Metastatic Melanoma
NCT01009515Phase 2Terminated
- Sponsor
- New Mexico Cancer Research Alliance
- Start
- Aug 2009
- Primary completion
- Sep 2013
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of carboplatin, paclitaxel, temozolomide in melanoma, sponsored by New Mexico Cancer Research Alliance. Started Aug 2009; status: terminated.
02
Drugs
carboplatinpaclitaxeltemozolomide
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT01009515.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01009515.